Item 8.01. Other Events.

On November 29, 2022, 9 Meters Biopharma, Inc. (the "Company") issued a press release announcing the design of its Phase 3 clinical trial of vurolenatide for adults with short bowel syndrome. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

On November 29, 2022, the Company updated its corporate presentation which can be found on the Company's website at www.9meters.com under the section titled Investors. A copy of the Company's presentation is filed as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference herein.




Item 9.01.     Financial Statements and Exhibits.



(d) Exhibits

Exhibit No.           Description
Exhibit 99.1            Press Release dated November 29, 2022.
Exhibit 99.2            9 Meters Biopharma, Inc. Corporate Presentation.
Exhibit 104           Cover Page Interactive Data File (embedded within the Inline XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses